Ever­est Med­i­cines be­gins pro­duc­tion at its new $129M+ mR­NA vac­cine man­u­fac­tur­ing fa­cil­i­ty in Chi­na

The Chi­na-based biotech Ever­est Med­i­cines has opened the doors to a new man­u­fac­tur­ing fa­cil­i­ty to pro­duce mR­NA-based vac­cines.

Ever­est’s new fa­cil­i­ty, which is lo­cat­ed just …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER